Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod effects on brain adaptation and cognition in relapsing-remitting multiple sclerosis
NL-OMON24446Not yet recruiting
- Sponsor
- VU University Medical Center
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of fingolimod in multiple sclerosis (MS), sponsored by VU University Medical Center. Primary endpoints: Improved neuropsychological test performance, Changed functional MRI/connectivity and 1 more. Planned start Aug 2014; status: not yet recruiting.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON24446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24446.